+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automatic Parallel Peptide Synthesiser Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6080490
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Automatic Parallel Peptide Synthesiser Market is projected to reach USD 387.98 Million in 2026. It is expected to continue growing at a CAGR of 10.18%, reaching USD 693.74 Million by 2032.

Automatic Parallel Peptide Synthesis: Executive Overview

Automatic parallel peptide synthesis systems enable multiple peptide sequences to be produced simultaneously under programmable laboratory conditions. They combine liquid handling, reagent delivery, temperature control, reaction monitoring, washing, and cleavage workflows to improve experimental consistency and throughput in discovery, process development, analytical research, and educational settings. Demand is shaped by the growing complexity of peptide libraries, the need to reduce manual handling, and broader adoption of automated workflows in life-science laboratories.

Automation, Miniaturization, and Workflow Integration Are Reshaping Peptide Synthesis

The landscape is shifting from stand-alone instruments toward integrated platforms that connect synthesis, purification, analytical testing, and data management. Miniaturized reaction formats can support efficient use of costly reagents, while modular architectures allow laboratories to configure systems for different sequence lengths, chemistries, and batch sizes. Usability is also becoming more important: guided software, standardized protocols, remote monitoring, and traceable run records help laboratories manage reproducibility, training, and regulatory documentation.

Artificial Intelligence Is Strengthening Design, Control, and Data Interpretation

Artificial intelligence is contributing to peptide synthesis through sequence prioritization, retrosynthetic planning, reagent and condition selection, anomaly detection, and interpretation of analytical results. Machine-learning tools can help identify difficult sequences and recommend experimental adjustments, while process-control models may detect deviations in coupling efficiency, temperature, or reagent delivery. The practical value of AI depends on high-quality experimental data, transparent validation, interoperability with laboratory systems, and appropriate human review; it should complement rather than replace chemical expertise and laboratory controls.

Regional Insights: Adoption Reflects Research Intensity and Laboratory Infrastructure

North America combines strong pharmaceutical, biotechnology, academic, and contract-research activity with broad access to automated laboratory infrastructure. Europe benefits from established chemical biology capabilities, collaborative research networks, and emphasis on reproducibility and compliance. Asia-Pacific is supported by expanding biopharmaceutical research, manufacturing capabilities, and investment in laboratory automation. Latin America is developing adoption through universities, pharmaceutical laboratories, and shared research facilities, although procurement and technical-support constraints can influence implementation. The Middle East is building advanced research capacity in selected institutions and healthcare-related innovation programs, while Africa shows opportunity in specialized academic, public-health, and translational laboratories where infrastructure, funding, and local service support are key considerations.

Group Insights: Collaborative Blocs Influence Standards, Procurement, and Capability Building

ASEAN laboratories are increasingly connected through regional research and manufacturing networks, creating interest in scalable systems, training, and service support. BRICS members span diverse scientific and industrial capabilities, with adoption influenced by domestic research priorities, procurement conditions, and efforts to strengthen local biotechnology capacity. The European Union emphasizes harmonized research practices, sustainability, data integrity, and cross-border collaboration. G7 members generally have mature life-science ecosystems and strong demand for reproducible, digitally connected workflows. GCC countries are investing in advanced research infrastructure and talent development, while NATO members benefit from extensive scientific collaboration and laboratory capabilities across defense, healthcare, and academic applications.

Country Insights: National Research Ecosystems Shape Use Cases and Deployment

Australia supports peptide research through universities, medical research organizations, and biotechnology activity. Brazil and Mexico are developing applications across academic, pharmaceutical, and public research laboratories. Canada and the United States have broad demand from biotechnology, pharmaceutical research, and contract laboratories. China, India, Japan, and South Korea combine substantial scientific capacity with expanding automation and biopharmaceutical activity. France, Germany, Italy, Spain, and the United Kingdom have established research and industrial bases, with strong attention to quality systems and workflow integration. Russia maintains scientific capabilities in selected institutions, although access to equipment, components, and international collaboration can affect deployment. Across these countries, the principal differentiators are technical support, compatibility with existing laboratory systems, operator training, and the ability to reproduce validated protocols.

Action Priorities for Leaders: Build Flexible, Connected, and Validated Workflows

Industry leaders should match instrument configuration to actual sequence diversity, throughput requirements, chemistry constraints, and downstream purification capacity rather than selecting automation solely on nominal parallelism. Prioritize open data interfaces, robust method transfer, audit trails, preventive maintenance, and locally accessible technical support. Establish validation protocols using representative difficult sequences, measure reagent and consumable utilization, and document failure modes before broad deployment. Organizations should also invest in operator training, cybersecurity, AI governance, and cross-functional collaboration among chemists, automation specialists, analytical scientists, and quality teams.

Research Methodology: Structured Synthesis of Verified Market-Relevant Evidence

This executive summary uses the defined market scope of automatic parallel peptide synthesis and organizes findings around technology evolution, laboratory use, artificial intelligence, geography, and strategic implementation. Insights are framed qualitatively from established characteristics of peptide chemistry, laboratory automation, biotechnology research, and regional scientific infrastructure. No market estimates, market shares, forecasts, or company-specific claims are used. Regional, group, and country observations are presented as contextual interpretations and should be validated against current institutional, regulatory, procurement, and technology-specific evidence before operational decisions are made.

Conclusion: Automation Enables More Reproducible and Scalable Peptide Research

Automatic parallel peptide synthesizers are becoming important tools for laboratories seeking greater experimental consistency, improved resource control, and faster evaluation of peptide designs. The strongest opportunities are associated with integrated workflows, data-rich process management, and carefully governed use of artificial intelligence. Successful adoption will depend less on instrument capacity alone and more on validated chemistry, interoperability, skilled personnel, dependable service, and alignment with each laboratory’s research and quality requirements.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Automatic Parallel Peptide Synthesiser Market, by Technology
7.1. Introduction
7.2. Liquid Phase
7.2.1. Membrane Assisted
7.2.2. Solution Phase
7.3. Solid Phase
7.3.1. Boc Chemistry
7.3.2. Fmoc Chemistry
8. Automatic Parallel Peptide Synthesiser Market, by Synthesis Scale
8.1. Introduction
8.2. High Throughput
8.3. Low Throughput
8.4. Medium Throughput
9. Automatic Parallel Peptide Synthesiser Market, by Applications
9.1. Introduction
9.2. Diagnostics
9.3. Research And Development
9.4. Therapeutics
9.5. Vaccine Development
10. Automatic Parallel Peptide Synthesiser Market, by End Users
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. Automatic Parallel Peptide Synthesiser Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Automatic Parallel Peptide Synthesiser Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Automatic Parallel Peptide Synthesiser Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 2B Scientific Limited
15.2. AAPPTec LLC
15.3. ABclonal, Inc.
15.4. Advanced ChemTech by Thorn BioScience LLC
15.5. Almac Group Limited
15.6. AmbioPharm Inc.
15.7. AnaSpec Inc.
15.8. Bachem AG
15.9. Biocon Limited
15.10. BioDuro LLC
15.11. Biosynth Ltd.
15.12. Biotage AB
15.13. CEM Corporation
15.14. CPC Scientific Inc.
15.15. Creative Diagnostics
15.16. CSBio, Inc.
15.17. Enamine Ltd.
15.18. GenScript Biotech Corporation
15.19. Intavis Bioanalytical Instruments AG
15.20. Merck KGaA
15.21. Protein Technologies LLC
15.22. Shimadzu Corporation
15.23. SPT Labtech Ltd.
15.24. Tecan Group Ltd.
15.25. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Automatic Parallel Peptide Synthesiser Market, Years Considered for the Study
FIGURE 2. Global Automatic Parallel Peptide Synthesiser Market, Research Design
FIGURE 3. Global Automatic Parallel Peptide Synthesiser Market, Research Framework
FIGURE 4. Global Automatic Parallel Peptide Synthesiser Market, Data Triangulation
FIGURE 5. Global Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2025 vs 2032 (%)
FIGURE 9. Global Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2025 vs 2032 (%)
FIGURE 11. Global Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2025 vs 2032 (%)
FIGURE 13. Global Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Automatic Parallel Peptide Synthesiser Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Automatic Parallel Peptide Synthesiser Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Automatic Parallel Peptide Synthesiser Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Automatic Parallel Peptide Synthesiser Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Automatic Parallel Peptide Synthesiser Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Automatic Parallel Peptide Synthesiser Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Automatic Parallel Peptide Synthesiser Market Segmentation & Coverage
TABLE 2. Global Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 3. Global Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Liquid Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Liquid Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Liquid Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Membrane Assisted Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Membrane Assisted Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Membrane Assisted Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Solution Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Solution Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Solution Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Solid Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Solid Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Solid Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Boc Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Boc Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Boc Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Fmoc Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Fmoc Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Fmoc Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 23. Global High Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global High Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global High Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Low Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Low Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Low Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Medium Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Medium Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Medium Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 33. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Research And Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Research And Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Research And Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 46. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 66. North America Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 68. North America Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 69. North America Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 70. North America Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 71. North America Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 72. North America Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 73. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 75. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 76. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 77. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 78. Latin America Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 79. Latin America Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 80. Europe Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 82. Europe Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 83. Europe Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 84. Europe Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 85. Europe Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 86. Europe Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 87. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 90. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 91. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 92. Middle East Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 93. Middle East Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 94. Africa Automatic Parallel Peptide Synthesiser Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Africa Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. Africa Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 97. Africa Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 98. Africa Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 99. Africa Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 100. Africa Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 101. Global Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 105. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 106. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 107. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 108. ASEAN Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 109. GCC Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. GCC Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. GCC Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 112. GCC Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 113. GCC Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 114. GCC Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 115. GCC Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 116. European Union Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. European Union Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. European Union Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 119. European Union Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 120. European Union Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 121. European Union Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 122. European Union Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 123. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 125. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 126. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 127. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 128. BRICS Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 129. BRICS Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 130. G7 Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. G7 Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. G7 Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 133. G7 Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 134. G7 Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 135. G7 Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 136. G7 Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 137. NATO Automatic Parallel Peptide Synthesiser Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. NATO Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. NATO Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 140. NATO Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 141. NATO Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 142. NATO Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 143. NATO Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 144. Global Automatic Parallel Peptide Synthesiser Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. United States Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 146. United States Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. United States Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 148. United States Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 149. United States Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 150. United States Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 151. United States Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 152. Canada Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 153. Canada Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Canada Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 155. Canada Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 156. Canada Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 157. Canada Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 158. Canada Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 159. Mexico Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 160. Mexico Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. Mexico Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 162. Mexico Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 163. Mexico Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 164. Mexico Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 165. Mexico Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 166. Brazil Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 167. Brazil Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. Brazil Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 169. Brazil Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 170. Brazil Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 171. Brazil Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 172. Brazil Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 173. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 174. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 176. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 177. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 178. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 179. United Kingdom Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 180. Germany Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 181. Germany Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. Germany Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 183. Germany Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 184. Germany Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 185. Germany Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 186. Germany Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 187. France Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 188. France Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. France Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 190. France Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 191. France Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 192. France Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 193. France Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 194. Russia Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 195. Russia Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Russia Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 197. Russia Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 198. Russia Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 199. Russia Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 200. Russia Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 201. Italy Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 202. Italy Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Italy Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 204. Italy Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 205. Italy Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 206. Italy Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 207. Italy Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 208. Spain Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 209. Spain Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. Spain Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 211. Spain Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 212. Spain Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 213. Spain Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 214. Spain Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 215. China Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 216. China Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. China Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 218. China Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 219. China Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 220. China Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 221. China Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 222. India Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 223. India Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. India Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 225. India Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 226. India Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 227. India Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 228. India Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 229. Japan Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 230. Japan Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. Japan Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 232. Japan Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 233. Japan Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 234. Japan Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 235. Japan Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 236. Australia Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 237. Australia Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. Australia Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 239. Australia Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 240. Australia Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 241. Australia Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 242. Australia Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 243. South Korea Automatic Parallel Peptide Synthesiser Market Size, 2017-2032 (USD Million)
TABLE 244. South Korea Automatic Parallel Peptide Synthesiser Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. South Korea Automatic Parallel Peptide Synthesiser Market Size, by Liquid Phase, 2017-2032 (USD Million)
TABLE 246. South Korea Automatic Parallel Peptide Synthesiser Market Size, by Solid Phase, 2017-2032 (USD Million)
TABLE 247. South Korea Automatic Parallel Peptide Synthesiser Market Size, by Synthesis Scale, 2017-2032 (USD Million)
TABLE 248. South Korea Automatic Parallel Peptide Synthesiser Market Size, by Applications, 2017-2032 (USD Million)
TABLE 249. South Korea Automatic Parallel Peptide Synthesiser Market Size, by End Users, 2017-2032 (USD Million)
TABLE 250. Global Automatic Parallel Peptide Synthesiser Market Share, by Key Player, 2025
TABLE 251. Global Automatic Parallel Peptide Synthesiser Market, Key Experts

Companies Mentioned

  • 2B Scientific Limited
  • AAPPTec LLC
  • ABclonal, Inc.
  • Advanced ChemTech by Thorn BioScience LLC
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • BioDuro LLC
  • Biosynth Ltd.
  • Biotage AB
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • CSBio, Inc.
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Intavis Bioanalytical Instruments AG
  • Merck KGaA
  • Protein Technologies LLC
  • Shimadzu Corporation
  • SPT Labtech Ltd.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.